Note 15 - Segments
|3 Months Ended|
Mar. 31, 2018
|Notes to Financial Statements|
|Segment Reporting Disclosure [Text Block]||
We report information about our operating segments using the “management approach” in accordance with current accounting standards. This information is based on the way management organizes and reports the segments within the enterprise for making operating decisions and assessing performance. Our reportable segments are identified based on differences in products, services and markets served. There were
nointer-segment sales. We manage our business based on
twoprimary types of drug products: (i) diagnostic substances, including Tc
99mtilmanocept and other diagnostic applications of our Manocept platform, and
NAV4694,and (ii) therapeutic development programs, including therapeutic applications of our Manocept platform and all development programs undertaken by MT.
The information in the following tables is derived directly from each reportable segment’s financial reporting.
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef